Dundee spinout Exscientia is continuing a busy fundraising year with a filing for an IPO in the US and a $35m concurrent private placement.

Exscientia, a UK-based drug discovery technology spinout of University of Dundee, filed for an initial public offering in the US on Friday, using a customary $100m placeholder amount. The spinout has not yet determined how many American Depositary Shares it will issue, or at what price, but has secured a commitment from Bill and Melinda…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.